Drug price policy in Chinese public hospitals

Aug 2017

The Chinese government has been driving healthcare price reform in the past five years. Drug price addition is in the process of abolishing in public hospitals from county-level to municipal, to break the old healthcare system started from 1950s. This report analyses the drug price policies and influences to Chinese public hospitals in recent years and provides suggestions on how to react. 

Contact us

Sabrianna Xing

Healthcare Consulting Partner, PwC Hong Kong

Tel: +[86] (10) 6533 2939

Follow us